TECHNOLOGY UPDATE
Dual-head injector with simultaneous injection
Images anywhere, any time Referring physicians today
The Optivantage dual-head com- puted tomography (CT) contrast media delivery system with simulta- neous injection has been launched by the pharmaceuticals division of Covidien. In combination with existing features such as the Optibolus bolus shaping software and the ability of the injector to use proprietary prefilled syringe tech- nology, the new injector enhances the company’s focus on patient care and hygiene in contrast media delivery. “The Optivantage injector with Simultaneous Injection has the capability to deliver dual injec- tion protocols of contrast media and saline, allowing technicians additional programming flexibility during scans,” said Stefano Copetti, Product Manager, Imaging Devices. “Physicians across the global have requested Simultaneous Injection and this feature supports mod- ern CT technology.” Simultaneous Injection and prefilled syringes offer technicians flexibility: the prefilled syringes also help minimize the risk of contamination from filling empty syringes, and the Optibolus software delivers contrast media at a decel- erating exponential rate compared to the standard constant rate of uni- phasic injections. COVIDIEN DUBLIN, IRELAND
www.covidien.com
APRIL/MAY 2012
demand easy access to online images and exam results. They require a simple and intuitive sys- tem to view images from anywhere and at anytime. CARESTREAM Vue Motion uses the latest pure- web technology providing access from multiple platforms. There is no need to download any software nor is there any compromise on performance or ease of use. Vue Motion can be implemented as part of a Carestream solution, and since it is PACS-agnostic, it can be inte- grated with a 3rd party PACS or DICOM archive. The zero-footprint Vue Motion provides referring phy- sicians easy and intuitive access to view image exams and other exam- related data in their offices—or on the move. Its intuitive design mini- mizes training and enables rapid adoption when embedded within EMR/HIS type portals. There’s no need to learn multiple products or perform duplicate log-ons. With Vue Motion’s
intuitive
design, users require little or no training. Zero footprint means no application software to install or maintain, and it enables rapid adoption by enterprise users. The viewing experience is enhanced with high-speed performance when pure-web based technology is supported by a back-end render- ing and streaming mechanism. Vue Motion also includes Web service
The new RaySafe i2 active
dosimeter gives medical staff real- time insight about their individual radiation exposure By using the system during imaging procedures, medical personnel are able to get instant information on their cur- rent exposure to X-ray, giving them the information needed to adjust as necessary their behavior so to minimize
exposure. The Unfors
RaySafe company is the world’s only manufacturer of real-time personal dosimetry systems. Published stud- ies have shown that a reduction in dose to personnel up to 40% can be achieved by using the company’s real-time dosimetry technology. Workplace efficiency and safety can be improved, and work processes streamlined,
through use of the
time-stamped, dose data collected by RaySafe i2. The basic package comes with one real time display, 4 dosimeters, and can be extended with additional dosimeters and advanced data management soft- ware. “Like the canary in the coal continued on page 52
DI EUROPE 51
access available for direct access to the data and enables access to data originated from a variety of clinical systems. These systems may produce data using standards such as HL7, DICOM or XDS. Non- DICOM image data and other types are also supported,
not limited to PDF, JPEG, AVI. CARESTREAM HEALTH ROCHESTER, NY, USA
www.carestream.com.
Dosimeter for real-time insight into individual radiation exposure
including but
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56